about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseCharacterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/Calcineurin and differential mRNA plyadenylationImmunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantationInflammatory bowel disease: an increased risk factor for neurologic complicationsTolerance in liver transplantation: Biomarkers and clinical relevanceThe calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosisSirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brainAutologous cord blood therapy for infantile cerebral palsy: from bench to bedside.Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literatureReversible posterior leukoencephalopathy syndrome: a misnomer reviewed.Neurotoxicity of immunosuppressive drugs.Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy.Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcomeImmunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolismTraditional treatment of human and animal salmonelloses in Southern Benin: Knowledge of farmers and traditherapists.Medication neurotoxicity in children.High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.Back to the future: oral targeted therapy for RA and other autoimmune diseases.Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.Central nervous system infection during immunosuppression.Severe cutaneous adverse drug reactions.Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptionsAlterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.Hypertensive encephalopathy and cerebral infarction.Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatmentDiagnosis and treatment of status epilepticus in a pediatric renal recipient.Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury.Seizure treatment in transplant patients.Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trialPharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Posterior reversible encephalopathy syndrome in children with kidney disease.Chlamydia pneumoniae infection-related hemophagocytic lymphohistiocytosis and acute encephalitis and poliomyelitis-like flaccid paralysis.Posterior reversible encephalopathy syndrome in children with kidney diseases.Beyond the joints: neurological involvement in rheumatoid arthritis.Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.Nonsurgical care of intestinal and multivisceral transplant recipients: a review for the intensivist.Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.
P2860
Q22241416-A379B65E-50E5-4729-986B-0EF8B8B87E20Q24290249-CCAC446D-67A0-4417-8FEF-894EA13AEDE7Q26751433-C871435B-1E34-48E6-837C-53BEEAE83BFCQ27690759-D66CFF97-FAA3-45EF-88A4-77D6CE477672Q28079523-0CEE7917-2245-4062-962A-DB63A78A68CAQ28142953-57F8FAC8-9CFE-4229-91B3-AAF9830C7B57Q28343921-EB7F3046-51BA-48AA-AF42-8A5642060E36Q30574180-C2F1D8F8-7331-4E03-928D-39A69F70AACEQ30874058-2AD89553-8202-4C61-B389-044FDD96C2E2Q30982510-4C78BE60-F676-4057-8BAD-4ABFF2340A84Q32031478-77539192-0EAA-455F-AD32-6D43326A16A5Q33414469-D72BAAA9-6AE6-4244-BD66-6330DC5E3EC7Q33575576-16200E0A-367A-4E60-B850-DD790B8D1F40Q33692314-E0342EF8-7243-495F-BE01-D76514E90BC2Q33738391-82CA3697-5477-476E-8298-48F2EF77841CQ33877128-D6893645-CB29-46CF-9AF7-A2634DC9B4F0Q33970034-B55DA607-A958-46D2-93BE-EF46AB308D4CQ33998443-D0D7EC7A-31CE-47E1-8B4F-3BD34C74AB0AQ34213332-45E44453-E19D-43AB-8009-E63DD185F69DQ34461277-AF89DE7F-B9BD-476B-A067-46AF59880824Q34469041-C3E6B7D5-3376-4638-88C1-A9EE3632D0BBQ34525532-159B0114-6CA2-41F8-9CBD-D5B18D374808Q34814081-BB4C7FA1-5E7E-4ABA-9F9E-ED26363632CEQ35047701-13A7BCCB-A3B6-40BA-B635-8B93B589A523Q35111469-3B059F15-6054-4C21-8802-E686C51B2657Q35537563-D6444FD3-0151-45E3-862F-3DA9B32FBAD4Q36143358-37774E37-81A9-41E4-9A1E-199AC36B8CCBQ36417575-FB787B68-CC03-49B7-9488-F83F9AA9C497Q36791214-DAFA224F-B7DE-4FE7-90CB-2F9B2F5F95F2Q36851252-1F0B0EAF-950B-42D4-814A-BAB841A9C2B5Q37098276-45D18F4C-2665-43C1-A404-4E49A0DAF6CFQ37508249-8EDC171B-F248-4F85-AAE2-6A47F163E864Q37589780-630FB1EC-F839-43AE-B470-6BA65290BD9FQ37851268-CF3D545C-C158-4822-8A28-8CC02CD50727Q37873782-70746A5B-6BEF-4EF3-8E8D-311056107AE6Q37935613-1216DD51-CD6D-4A2C-81A5-771FAA984730Q38007126-D4572070-A1F2-468F-B25F-8951FEA1AB9AQ38021735-88E161E2-D407-4344-948F-CE5CD54752B8Q38028790-6D3FAE91-AE7C-424B-8828-F60C2E7A8A10Q38043510-4BFD0091-5EF1-4FEA-A56B-8F84DB31FD95
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cyclosporine neurotoxicity: a review.
@ast
Cyclosporine neurotoxicity: a review.
@en
type
label
Cyclosporine neurotoxicity: a review.
@ast
Cyclosporine neurotoxicity: a review.
@en
prefLabel
Cyclosporine neurotoxicity: a review.
@ast
Cyclosporine neurotoxicity: a review.
@en
P2093
P356
P1433
P1476
Cyclosporine neurotoxicity: a review.
@en
P2093
Gijtenbeek JM
van den Bent MJ
P2888
P304
P356
10.1007/S004150050360
P577
1999-05-01T00:00:00Z
P6179
1048339900